Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate and document longitudinal efficacy in young children implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant systems.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Med-El Corporation
NCT07646119 · Hidden Hearing Loss
NCT06960616 · Deafness, Cochlear Hearing Loss
NCT06354010 · Sensorineural Hearing Loss, Bilateral
NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more
NCT05365646 · Hearing Loss, Dizziness, and more
Nemours Children's Clinic
Jacksonville, Florida
Children's Healthcare of Atlanta
Atlanta, Georgia
Cleveland Clinic Foundation
Cleveland, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions